Journal Article Comment Ppublish 7 citations
PubMed: 35338839 DOI: 10.1016/S2213-2600(22)00123-0
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
Lancet Respir Med 10(6):529-531
Authors: Molebogeng X Rangaka, Yohhei Hamada, Ibrahim Abubakar
Affiliations
- Institute for Global Health, University College London, London WC1N 1EH, UK; MRC Clinical Trials Unit, University College London, London, UK; Clinical Infectious Diseases Research Initiative (CIDRI)-AFRICA and School of Public Health, University of Cape Town, Cape Town, South Africa.
- Institute for Global Health, University College London, London WC1N 1EH, UK.
- Faculty of Population Health Sciences, University College London, London, UK.
MeSH
Covid-19, Tuberculosis, Syndemic